United Biotech Private Limited
United Biotech Private Limited
Badarpur, New Delhi, Delhi
SEND SMS
SEND EMAIL

Cardiac Drugs

Leading manufacturer of cardiac drugs from India, we offer high quality medicines for heart patients which includes intensive cardiac care unit (ICCU) products like Cardioplegic solution, alprostadil, eptifibatide, tirofiban, enoxaparin, streptokinase, citicholine and many others.

Sterile Cardioplegia Solution20 ml

Sterile Cardioplegia Solution20 ml
  • Sterile Cardioplegia Solution20 ml
Ask For Price
Product Price :Get Latest Price

Product Details:

ApplicationAnti Infective & Common Disease Medicines
Injectable FormSolution
Packaging Size1 Ampoule of 20 ml
Dose10ml-20ml
Packaging TypeGlass Bottle
Medicine TypeAllopathic

Indications :
  • BIOPLEGIA used to induce cardiac arrest during open heart surgery. For the surgical management of ischemic heart disease with local hypothermia.

Dosages :
The initial rate of infusion may be 300 mL/m²/minute given for a period of two to four minutes.
If myocardial electromechanical activity persists or recur, the solution may be reinfused at a rate of 300 mL/m²/min for a period of two minutes. Reinfusion of the solution may be repeated every 20 to 30 minutes or sooner if the myocardial temperature rises above 15° to 20°C or returning cardiac activity is observed.

Packing:
1 Ampoule of 20 ml
Request
Callback
Yes! I am Interested

Metolazone Tablets 2.5mg and 5mg

Metolazone Tablets 2.5mg and 5mg
  • Metolazone Tablets 2.5mg and 5mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Product TypeAPI
Dose2.5mg and 5mg
UsageClinical, Hospital
Packaging Size1 Strip of 10 Tablets
Packing typeBox

Indications :
  • Hypertension
  • Salt and water retention

Dosages :
  • Hypertension : 2.5-5 mg OD
  • Salt and water retention: 5-20 mg OD
  • Dosage Adjustment :
  • Renal Impairment: May be required.
  • Hepatic Impairment: May be required.

Packing :
1 Strip of 10 Tablets
Request
Callback
Yes! I am Interested

Nimodipine Tablets 30mg

Nimodipine Tablets 30mg
  • Nimodipine Tablets 30mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Packaging TypeTablets
UsageIndustrial, Laboratory
Packaging Size1 Strip of 10 Tablets
Strength (mg)30 mg
Drug NameNimodipine

Indications :
  • Subarachnoid hemorrhage

Dosages :
Adult
Oral: 60 mg every 4 hrs for 21 days, start the therapy within 96 hrs after subarachnoid hemorrhage.
Paediatric: Not recommended.
Renally Impaired Patients : No dosage adjustment required.

Packing:
1 Strip of 10 Tablets
Request
Callback
Yes! I am Interested

Dalteparin Sodium Injection 2500 IU and 5000 IU

Dalteparin Sodium Injection 2500 IU and 5000 IU
  • Dalteparin Sodium Injection 2500 IU and 5000 IU
Ask For Price
Product Price :Get Latest Price

Product Details:

Product TypeAPI
UsageHospital, Clinical
Packaging Size1 Pre-filled Syringe of 2500 IU
Packaging TypeInjection

Indications :
  • Prophylaxis of Ischemic Complications in Unstable Angina and Non-Q-Wave Myocardial Infarction
  • Extended treatment of symptomatic venous thromboembolism (VTE), including proximal deep vein thrombosis (DVT) and pulmonary embolism (PE)
  • Prophylaxis of DVT, which may lead to PE (In patient undergoing hip replacement surgery, abdominal surgery, High-risk patient & cancer patient)

Renally Impaired Patients: Not known, administer with caution.

Packing :
1 Pre-filled Syringe of 2500 IU
1 Pre-filled Syringe of 5000 IU
Request
Callback
Yes! I am Interested

Tirofiban Hydrochloride Injection 5mg

Tirofiban Hydrochloride Injection 5mg
  • Tirofiban Hydrochloride Injection 5mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Dose/Strength (ex. 1 mg or 1ml)5 mg
Packaging Size1 Vial of 5 mg/100 ml
Packaging TypeInjection
UsageClinical, Hospital

Indications :
  • Acute Coronary Syndrome
  • Percutaneous Transluminal Coronary Angioplasty (PTCA)

Dosage :
Administration :
Use Tirofiban within 12 hrs of the last episode of the chest pain or ischemic ECG changes. Use Tirofiban in combination with
Dosage :
It should be administered intravenously, at an initial rate of 0.4 mcg/kg/min for 30 minutes and then continued at 0.1 mcg/kg/min for between 48 and 108 hrs (2-4.5 days).
Continue up to and during coronary angioplasty/ stenting if undertaken, and for at least 12-24 hrs afterward.
Renally Impaired Patients: Patients with severe renal insufficiency (creatinine clearance <30 mL/min) should receive half the usual rate of infusion.



Request
Callback
Yes! I am Interested

Phenylephrine Injection 10mg

Phenylephrine Injection 10mg
  • Phenylephrine Injection 10mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Product TypeFinished Product
Dose10 mg
UsageHospital, Clinical
Packaging Size1 Amp. of 10mg/1ml

indications :
Blood pressure maintenance :
  • Severe hypotension and shock
  • Spinal anesthesia
  • Prolongation of spinal anesthesia
  • Vasoconstrictor for regional anesthesia
  • Paroxysmal supraventricular tachycardia

Dosages :
Mild or moderate hypotension :
SC or IM –
The usual dose is from 2 to 5mg. The range is from 1 to 10mg.The initial dose should not exceed 5mg.
IV - The usual dose is 0.2mg. Initial dose should not exceed 0.5mg
Severe hypotension and shock :
Continuous infusion – Add 10 mg of the drug to 500ml of dextrose injection or sodium chloride injection. To raise the blood pressure rapidly start the infusion at about 100mcg to 180mcg/min.When the blood pressure is normalized, a maintenance rate of 40-60mcg/min usually suffices.
Spinal anesthesia :
SC or IM 3 or 4 minutes before injection of the spinal anesthetic.The total requirement for high anesthetic levels is usually 3mg and for lower levels 2mg. For hypotensive emergencies during spinal anesthesia phenylephrine may be injected IV, using an initial dose of 0.2mg Any subsequent dose should not exceed the previous dose by more than 0.1 to 0.2mg and no more than 0.5mg should be administered in a single dose.
Prolongation of spinal anesthesia :
The addition of 2 to 5mg of phenylephrine of to the anesthetic solution increases the duration of motor block by as much as approx.50%.
Vasoconstrictor for regional anesthesia :
Conc. About 10 times those employed when is used as a vasoconstrictor are recommended.The optimum strength is 1:20000(made by adding 1mg of phenylephrine to every 20ml of local anesthetic solution).
Paroxysmal supraventricular tachycardia :
Rapid IV injection (within 20-30sec) is recommended. The initial dose should not exceed 0.5mg and subsequent doses which are determined by the initial blood pressure, should not exceed the preceding dose by more than 0.1-0.2mg and should never exceed 1mg

Packing:
1 Amp. of 10mg/1ml
Request
Callback
Yes! I am Interested

Sterile Cardioplegia Solution 20ml

Sterile Cardioplegia Solution 20ml
  • Sterile Cardioplegia Solution 20ml
Ask For Price
Product Price :Get Latest Price

Product Details:

Dose/Strength (ex. 1 mg or 1ml)20 ml
Packaging TypeLiquid
UsageClinical, Hospital
Packaging Size5 Ampoules of 20 ml

Indications :
  • BIOPLEGIA used to induce cardiac arrest during open heart surgery. For the surgical management of ischemic heart disease with local hypothermia

Dosage :
The initial rate of infusion may be 300 mL/m²/minute given for a period of two to four minutes.
If myocardial electromechanical activity persists or recur, the solution may be reinfused at a rate of 300 mL/m²/min for a period of two minutes. Reinfusion of the solution may be repeated every 20 to 30 minutes or sooner if the myocardial temperature rises above 15° to 20°C or returning cardiac activity is observed.

Packing: 5 Ampoules of 20 ml
Request
Callback
Yes! I am Interested

Recombinant Streptokinase 7.5 LIU and 15 LIU

Recombinant Streptokinase 7.5 LIU and 15 LIU
  • Recombinant Streptokinase 7.5 LIU and 15 LIU
Ask For Price
Product Price :Get Latest Price

Product Details:

Dose/Strength (ex. 1 mg or 1ml) 7.5 LIU and 15 LIU
Packaging Size1 Vial of 7.5 L
Packaging TypeBottle
UsageClinical, Hospital

Indications :
  • Acute Myocardial Infarction: Less than 12 hours
  • Deep Venous Thrombosis: Less than 14 days
  • Acute Massive Pulmonary Embolism
  • Acute Arterial Thrombosis and Embolism
  • Clotting in Haemodialysis Shunts

Dosages :
INDICATIONSDOSAGEINFUSION RATE
Acute Myocardial infarction15,00,000 IUOver 30-60 min
Deep Venous Thrombosis, Pulmonary
Embolism and Arterial Occlusions***
Loading Dose: 2,50,000 IU*
Maintenance Dose: 1,00,000 IU**
Loading Dose: Over 30 min
Maintenance Dose: 60 min

*STREPTONASE-R should be administered as soon as possible after the onset of symptoms of myocardial infarction. The greatest benefit in mortality reduction is achieved when Streptokinase is administered within the first 6 hours but the substantial benefit has been demonstrated for up to 12 hours.
**Administered for up to 3 days. If possible an angiographic assessment should then be performed. If no clinical effect is noted after 3 days, treatment should be discontinued.
*** Follow-up Treatment: After every course of recombinant streptokinase therapy, a follow-up treatment with anticoagulants or platelet aggregation inhibitors can be instituted as a prevention of thrombosis. With therapy, in particular, an increased risk of hemoglobin must be considered.
STREPTONASE-R therapy may otherwise be continued for an additional 1-3 days if considered necessary.

Packing :
1 Vial of 7.5 L
1 Vial of 15 L

Request
Callback
Yes! I am Interested

Streptokinase for Injection 7,50,000 IU and 15,00,000 IU

Streptokinase for Injection 7,50,000 IU and 15,00,000 IU
  • Streptokinase for Injection 7,50,000 IU and 15,00,000 IU
Ask For Price
Product Price :Get Latest Price

Product Details:

Dose/Strength (ex. 1 mg or 1ml)100 to 300 ml
Packaging Size1 Vial of 7,50,000 IU
Packaging TypeInjection
UsageHospital, Clinical

Indications :
  • Acute evolving transmural myocardial infarction
  • Acute deep vein thrombosis
  • Acute pulmonary embolism
  • Acute arterial thrombosis
  • Occlusion of arterio-venous cannulae

Dosages :
Acute evolving transmural myocardial infarction:1,500,000 I.U. IV over 30 to 60 minutes & maintenance dose of 2000 to 4000 I.U./min for 60 minutes by intra coronary infusion.
Deep vein thrombosis, pulmonary embolism, arterial thrombosis or embolism:A loading dose of 250,000 I.U. of streptokinase in 100 to 300 ml of IV infusion over 30-60 min.
A maintenance dose of 1,00,000 I.U./hour is given through infusion for 3 days.
Renally Impaired Patients : No dosage adjustment required.

Packing :
1 Vial of 7,50,000 IU
1 Vial of 15,00,000 IU
Request
Callback
Yes! I am Interested

Dobutamine for Injection 250mg

Dobutamine for Injection 250mg
  • Dobutamine for Injection 250mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Dose/Strength (ex. 1 mg or 1ml)250 mg
Packaging Size1 Ampoule of 250 mg/5 ml
Packaging TypeInjection
UsageHospital, Clinical

Indications :
  • Cardiac Decompensation

Dosages :
Adult Dose :
I.V. Infusion administered at a rate of 2.5 to 15mcg/kg of body weight/minute up to 40mcg/kg/minute.
Paediatric: Not recommended.
Renally Impaired Patients: Not known, administer with caution.

Packing:
1 Ampoule of 250 mg/5 ml
Request
Callback
Yes! I am Interested

Enoxaparin Sodium Injection 20mg, 40mg and 60mg

Enoxaparin Sodium Injection 20mg, 40mg and 60mg
  • Enoxaparin Sodium Injection 20mg, 40mg and 60mg
Ask For Price
Product Price :Get Latest Price

Product Details:

UsageClinical
Packaging TypeInjection
Packaging Size1 Pre-Filled Syringe
Dose/Strength60 mg

Indications :
  • Prophylaxis of Deep Vein Thrombosis, which may lead to Pulmonary Embolism.
  • In a patient undergoing Abdominal Surgery who are at risk for Thromboembolic Complications.
  • In patients undergoing Hip Replacement Surgery, during & following hospitalization In patients undergoing Knee Replacement Surgery.
  • In a medical patient who is at risk for Thromboembolic Complications due to severely restricted mobility during acute illness.
  • Prophylaxis of ischemic complication of unstable angina & Non-Q wave myocardial infarction, when concurrently administered with.
  • Acute deep vein thrombosis with or without pulmonary embolism, when administered in conjunction with sodium.

Dosage :
Abdominal Surgery: 40mg once a day administered by SC in. with the initial dose given 2hr. prior to surgery. The usual duration of administration is 7 to 10 days.
Hip Or Knee Replacement Surgery: 30mg every 12 hr. administered by SC. in. continue prophylaxis with 40mg once a day administered by SC, in. for 3 weeks is recommended. The usual duration of administration is 7 to 10 days.
Medical Patient During Acute Illness: 40mg. once a day administered by SC, in. The usual duration of administration is 6 to 11 days.
Unstable Angina & Non-Q- Wave Myocardial Infarction:1mg/kg administered SC every 12 hr. in conjunction with oral therapy (100 to 325mg once daily).
Treatment with enoxaparin injection should be prescribed for a minimum of 2 days and continued until clinical stabilization.
Treatment Of Deep Vein Thrombosis With Or Without Pulmonary Embolism :
In Outpatient Treatment:
1mg/kg every 12 hr. administered SC.
In Inpatient Treatment: 1mg/kg every 12 hr. administered SC at the same time every day.
Renally Impaired Patients :

Packing :
1 Pre-Filled Syringe
1 Pre-Filled Syringe
1 Pre-Filled Syringe
Request
Callback
Yes! I am Interested

Prazosin Tablets 1mg and 2mg

Prazosin Tablets 1mg and 2mg
  • Prazosin Tablets 1mg and 2mg
Ask For Price
Product Price :Get Latest Price

Product Details:

UsageHospital, Clinical
Dose/Strength (ex. 1 mg or 1ml)2 mg
Packaging Size1 Strip of 10 Tablets
Packaging TypeTablet box

Indications :
  • Hypertension.

Dosages :
Adults :
  • Initial dose: 1 mg BID-TID
  • Maintenance dose: 6-15 mg/day in divided doses
  • Concomitant Therapy:1-2 mg TID i.e. while adding a diuretic or other hypertensive drug.
  • Dosage Adjustment :
  • Renal Impairment : May be required in severe impairment.
  • Hepatic Impairment: May be required in severe impairment.

Packing :
1 Strip of 10 Tablets
Request
Callback
Yes! I am Interested

Tirofiban for Intravenous Infusion 12.5mg

Tirofiban for Intravenous Infusion 12.5mg
  • Tirofiban for Intravenous Infusion 12.5mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Packaging Size1 Vial of 12.5 mg/50 ml
Packaging TypeInfusion
Dose/Strength (ex. 1 mg or 1ml)12.5 mg
UsageClinical, Hospital

Indications :
  • Acute Coronary Syndrome
  • Percutaneous Transluminal Coronary Angioplasty (PTCA)

Dosage :
Administration :
Use Tirofiban within 12 hrs of the last episode of the chest pain or ischemic ECG changes. Use Tirofiban in combination with and.
Dosage :
It should be administered intravenously, at an initial rate of 0.4 mcg/kg/min for 30 minutes and then continued at 0.1 mcg/kg/min for between 48 and 108 hrs (2-4.5 days).
Continue up to and during coronary angioplasty/ stenting if undertaken, and for at least 12-24 hrs afterward.
Renally Impaired Patients: Patients with severe renal insufficiency (creatinine clearance <30 mL/min) should receive half the usual rate of infusion.

Packing :
1 Vial of 12.5 mg/50 ml
Request
Callback
Yes! I am Interested
X

Explore more products



Reach Us
United Biotech (Manager)
FC/B-1 Extension, Mohan Cooperative Industrial Estate Mathura Road
Badarpur, New Delhi- 110044, Delhi, India



Call Us

Share Us

F GT L


Send E-mailSend SMS